Strengthening the Fight Against Fraud, Waste, and Abuse in Medicare and Medicaid

Fraud, waste, and abuse (FWA) in Medicare and Medicaid are significant challenges that threaten the sustainability of these programs, reduce access to care for vulnerable Americans, increase taxpayer costs, and undermine trust in the healthcare system. The recent House Energy and Commerce Committee Oversight and Investigations Subcommittee hearing, titled “Protecting Patients and Safeguarding Taxpayer Dollars: The Role of CMS in Combatting Medicare and Medicaid Fraud,” shine a light on the current state of FWA and efforts to address it.

The Scope of Fraud, Waste, and Abuse

The hearing addressed the distinction between fraud, waste, and abuse.  While improper payments may result from administrative errors or misinterpretations, deliberate fraud involves intentional schemes to exploit the system. Both issues require tailored strategies to ensure effective oversight without compromising access to care. These challenges collectively cost taxpayers billions of dollars annually and compromise the quality of care for beneficiaries. Congressman John Joyce, M.D. (PA-13), Chair of the Subcommittee on Oversight and Investigations, highlighted the widespread nature of these issues, citing examples across multiple sectors and states.

Bipartisan Focus on Program Integrity

The hearing underscored a bipartisan commitment to addressing FWA. Congressman Brett Guthrie (KY-02), Chair of the House Energy and Commerce Committee, emphasized the importance of ensuring that resources are directed to legitimate care and not diverted by fraudulent actors. Congresswoman Yvette Clarke (NY-09), Ranking Member of the Subcommittee on Oversight and Investigations, and Congressman Frank Pallone (NJ-06), Ranking Member of the full Energy and Commerce Committee, raised concerns about the potential for anti-fraud measures to disproportionately impact certain states or populations, while also affirming the need for consistent and effective oversight.

Witnesses and lawmakers alike stressed the importance of maintaining program integrity while ensuring that anti-FWA efforts do not disrupt access to care for beneficiaries. This balance is critical to preserving the sustainability of Medicare and Medicaid.

Shifting Strategies to Combat FWA

Kim Brandt, Deputy Administrator and Chief Operating Officer of the Centers for Medicare & Medicaid Services (CMS), outlined the agency’s evolving approach to addressing FWA. CMS is transitioning from reactive enforcement to proactive prevention, leveraging data analytics, machine learning, and real-time monitoring to identify and address issues before they escalate. For example, CMS’s Fraud Defense Operations Center uses predictive algorithms to detect suspicious billing patterns, enabling targeted oversight.

Brandt also highlighted the agency’s efforts to enhance provider screening, conduct site visits, and collaborate with law enforcement to address fraudulent activities. These measures aim to reduce improper payments, prevent waste, and ensure that resources are allocated appropriately.

Leveraging Technology and Innovation

Technology plays a central role in CMS’s efforts to combat FWA. The agency uses tools such as the Social Security Administration’s Death Master File to cross-check claims and predictive algorithms to flag high-risk providers. These innovations enable CMS to identify and address issues more efficiently, reducing the need for retrospective recovery efforts.

In addition to technological advancements, legislative proposals such as Congressman Greg Landsman’s (OH-01) initiative to study Medicaid coverage for costly wound care supplies highlight the potential for targeted policies to address waste and improve patient outcomes. By addressing systemic vulnerabilities, policymakers can enhance program integrity and reduce unnecessary expenditures.

A Coordinated Effort

Addressing FWA in Medicare and Medicaid requires collaboration across federal and state governments, private sector partners, and law enforcement agencies. Transparent decision-making, consistent enforcement, and data-driven strategies are essential to ensuring that these programs remain effective and sustainable. By focusing on prevention, oversight, and innovation, stakeholders can protect taxpayer dollars, safeguard patient care, and maintain trust in the healthcare system.